ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Analgesic Patch Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-13M12971
Home | Market Reports | Health| Health Conditions| Pain Management
Global Transdermal Analgesic Patch Market Research Report 2022
BUY CHAPTERS

Global Transdermal Analgesic Patch Market Research Report 2024

Code: QYRE-Auto-13M12971
Report
May 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hisamitsu Pharmaceutical
Johnson & Johnson
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr. Reddy’s Laboratories

Transdermal Analgesic Patch Market

The global Transdermal Analgesic Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Transdermal Analgesic Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Analgesic Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Analgesic Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem and Nitto Denko, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Analgesic Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Analgesic Patch.

Report Scope

The Transdermal Analgesic Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Analgesic Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Analgesic Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Transdermal Analgesic Patch Market Report

Report Metric Details
Report Name Transdermal Analgesic Patch Market
Segment by Type
  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others
Segment by Application
  • Rx Channel
  • OTC Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Grünenthal, Mundipharma, GSK, Luye Pharma Group, Bayer, IBSA Group, Dr Reddy’s Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transdermal Analgesic Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transdermal Analgesic Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Transdermal Analgesic Patch Market report?

Ans: The main players in the Transdermal Analgesic Patch Market are Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Grünenthal, Mundipharma, GSK, Luye Pharma Group, Bayer, IBSA Group, Dr Reddy’s Laboratories

What are the Application segmentation covered in the Transdermal Analgesic Patch Market report?

Ans: The Applications covered in the Transdermal Analgesic Patch Market report are Rx Channel, OTC Channel

What are the Type segmentation covered in the Transdermal Analgesic Patch Market report?

Ans: The Types covered in the Transdermal Analgesic Patch Market report are Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others

1 Transdermal Analgesic Patch Market Overview
1.1 Product Overview and Scope of Transdermal Analgesic Patch
1.2 Transdermal Analgesic Patch Segment by Type
1.2.1 Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2030)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Analgesic Patch Segment by Application
1.3.1 Global Transdermal Analgesic Patch Market Value by Application: (2024-2030)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Analgesic Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Analgesic Patch Revenue 2019-2030
1.4.2 Global Transdermal Analgesic Patch Sales 2019-2030
1.4.3 Global Transdermal Analgesic Patch Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Analgesic Patch Market Competition by Manufacturers
2.1 Global Transdermal Analgesic Patch Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Analgesic Patch Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Analgesic Patch Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Analgesic Patch Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Analgesic Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Analgesic Patch, Product Type & Application
2.7 Transdermal Analgesic Patch Market Competitive Situation and Trends
2.7.1 Transdermal Analgesic Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Analgesic Patch Players Market Share by Revenue
2.7.3 Global Transdermal Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Analgesic Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Analgesic Patch Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Analgesic Patch Global Transdermal Analgesic Patch Sales by Region: 2019-2030
3.2.1 Global Transdermal Analgesic Patch Sales by Region: 2019-2024
3.2.2 Global Transdermal Analgesic Patch Sales by Region: 2025-2030
3.3 Global Transdermal Analgesic Patch Global Transdermal Analgesic Patch Revenue by Region: 2019-2030
3.3.1 Global Transdermal Analgesic Patch Revenue by Region: 2019-2024
3.3.2 Global Transdermal Analgesic Patch Revenue by Region: 2025-2030
3.4 North America Transdermal Analgesic Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Analgesic Patch Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Analgesic Patch Sales by Country (2019-2030)
3.4.3 North America Transdermal Analgesic Patch Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Analgesic Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Analgesic Patch Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Analgesic Patch Sales by Country (2019-2030)
3.5.3 Europe Transdermal Analgesic Patch Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Analgesic Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Analgesic Patch Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Analgesic Patch Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Analgesic Patch Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transdermal Analgesic Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Analgesic Patch Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Analgesic Patch Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Analgesic Patch Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Analgesic Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Analgesic Patch Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Analgesic Patch Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Analgesic Patch Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Analgesic Patch Sales by Type (2019-2030)
4.1.1 Global Transdermal Analgesic Patch Sales by Type (2019-2024)
4.1.2 Global Transdermal Analgesic Patch Sales by Type (2025-2030)
4.1.3 Global Transdermal Analgesic Patch Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Analgesic Patch Revenue by Type (2019-2030)
4.2.1 Global Transdermal Analgesic Patch Revenue by Type (2019-2024)
4.2.2 Global Transdermal Analgesic Patch Revenue by Type (2025-2030)
4.2.3 Global Transdermal Analgesic Patch Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Analgesic Patch Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Analgesic Patch Sales by Application (2019-2030)
5.1.1 Global Transdermal Analgesic Patch Sales by Application (2019-2024)
5.1.2 Global Transdermal Analgesic Patch Sales by Application (2025-2030)
5.1.3 Global Transdermal Analgesic Patch Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Analgesic Patch Revenue by Application (2019-2030)
5.2.1 Global Transdermal Analgesic Patch Revenue by Application (2019-2024)
5.2.2 Global Transdermal Analgesic Patch Revenue by Application (2025-2030)
5.2.3 Global Transdermal Analgesic Patch Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Analgesic Patch Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Transdermal Analgesic Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Transdermal Analgesic Patch Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB Pharma Transdermal Analgesic Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Transdermal Analgesic Patch Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Corporation Information
6.6.2 Beijing Tide Pharmaceutical Description and Business Overview
6.6.3 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.8 Chattem
6.8.1 Chattem Corporation Information
6.8.2 Chattem Description and Business Overview
6.8.3 Chattem Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chattem Transdermal Analgesic Patch Product Portfolio
6.8.5 Chattem Recent Developments/Updates
6.9 Nitto Denko
6.9.1 Nitto Denko Corporation Information
6.9.2 Nitto Denko Description and Business Overview
6.9.3 Nitto Denko Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nitto Denko Transdermal Analgesic Patch Product Portfolio
6.9.5 Nitto Denko Recent Developments/Updates
6.10 Grünenthal
6.10.1 Grünenthal Corporation Information
6.10.2 Grünenthal Description and Business Overview
6.10.3 Grünenthal Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Grünenthal Transdermal Analgesic Patch Product Portfolio
6.10.5 Grünenthal Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Transdermal Analgesic Patch Description and Business Overview
6.11.3 Mundipharma Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mundipharma Transdermal Analgesic Patch Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Transdermal Analgesic Patch Description and Business Overview
6.12.3 GSK Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GSK Transdermal Analgesic Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Luye Pharma Group
6.13.1 Luye Pharma Group Corporation Information
6.13.2 Luye Pharma Group Transdermal Analgesic Patch Description and Business Overview
6.13.3 Luye Pharma Group Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Luye Pharma Group Transdermal Analgesic Patch Product Portfolio
6.13.5 Luye Pharma Group Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Transdermal Analgesic Patch Description and Business Overview
6.14.3 Bayer Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bayer Transdermal Analgesic Patch Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 IBSA Group
6.15.1 IBSA Group Corporation Information
6.15.2 IBSA Group Transdermal Analgesic Patch Description and Business Overview
6.15.3 IBSA Group Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.15.4 IBSA Group Transdermal Analgesic Patch Product Portfolio
6.15.5 IBSA Group Recent Developments/Updates
6.16 Dr Reddy’s Laboratories
6.16.1 Dr Reddy’s Laboratories Corporation Information
6.16.2 Dr Reddy’s Laboratories Transdermal Analgesic Patch Description and Business Overview
6.16.3 Dr Reddy’s Laboratories Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Dr Reddy’s Laboratories Transdermal Analgesic Patch Product Portfolio
6.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Analgesic Patch Industry Chain Analysis
7.2 Transdermal Analgesic Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Analgesic Patch Production Mode & Process
7.4 Transdermal Analgesic Patch Sales and Marketing
7.4.1 Transdermal Analgesic Patch Sales Channels
7.4.2 Transdermal Analgesic Patch Distributors
7.5 Transdermal Analgesic Patch Customers
8 Transdermal Analgesic Patch Market Dynamics
8.1 Transdermal Analgesic Patch Industry Trends
8.2 Transdermal Analgesic Patch Market Drivers
8.3 Transdermal Analgesic Patch Market Challenges
8.4 Transdermal Analgesic Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hisamitsu Pharmaceutical
Johnson & Johnson
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr. Reddy’s Laboratories
List of Tables
    Table 1. Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Transdermal Analgesic Patch Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Transdermal Analgesic Patch Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Transdermal Analgesic Patch Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Transdermal Analgesic Patch Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Transdermal Analgesic Patch Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Transdermal Analgesic Patch Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Transdermal Analgesic Patch Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Transdermal Analgesic Patch, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Transdermal Analgesic Patch, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Transdermal Analgesic Patch, Product Type & Application
    Table 12. Global Key Manufacturers of Transdermal Analgesic Patch, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Transdermal Analgesic Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesic Patch as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Transdermal Analgesic Patch Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Transdermal Analgesic Patch Sales by Region (2019-2024) & (K Units)
    Table 18. Global Transdermal Analgesic Patch Sales Market Share by Region (2019-2024)
    Table 19. Global Transdermal Analgesic Patch Sales by Region (2025-2030) & (K Units)
    Table 20. Global Transdermal Analgesic Patch Sales Market Share by Region (2025-2030)
    Table 21. Global Transdermal Analgesic Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Transdermal Analgesic Patch Revenue Market Share by Region (2019-2024)
    Table 23. Global Transdermal Analgesic Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Transdermal Analgesic Patch Revenue Market Share by Region (2025-2030)
    Table 25. North America Transdermal Analgesic Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Transdermal Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 27. North America Transdermal Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 28. North America Transdermal Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Transdermal Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Transdermal Analgesic Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Transdermal Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Transdermal Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Transdermal Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Transdermal Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Transdermal Analgesic Patch Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Transdermal Analgesic Patch Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Transdermal Analgesic Patch Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Transdermal Analgesic Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Transdermal Analgesic Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Transdermal Analgesic Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Transdermal Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Transdermal Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Transdermal Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Transdermal Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Transdermal Analgesic Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Transdermal Analgesic Patch Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Transdermal Analgesic Patch Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Transdermal Analgesic Patch Sales (K Units) by Type (2019-2024)
    Table 51. Global Transdermal Analgesic Patch Sales (K Units) by Type (2025-2030)
    Table 52. Global Transdermal Analgesic Patch Sales Market Share by Type (2019-2024)
    Table 53. Global Transdermal Analgesic Patch Sales Market Share by Type (2025-2030)
    Table 54. Global Transdermal Analgesic Patch Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Transdermal Analgesic Patch Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Transdermal Analgesic Patch Revenue Market Share by Type (2019-2024)
    Table 57. Global Transdermal Analgesic Patch Revenue Market Share by Type (2025-2030)
    Table 58. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Transdermal Analgesic Patch Sales (K Units) by Application (2019-2024)
    Table 61. Global Transdermal Analgesic Patch Sales (K Units) by Application (2025-2030)
    Table 62. Global Transdermal Analgesic Patch Sales Market Share by Application (2019-2024)
    Table 63. Global Transdermal Analgesic Patch Sales Market Share by Application (2025-2030)
    Table 64. Global Transdermal Analgesic Patch Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Transdermal Analgesic Patch Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Transdermal Analgesic Patch Revenue Market Share by Application (2019-2024)
    Table 67. Global Transdermal Analgesic Patch Revenue Market Share by Application (2025-2030)
    Table 68. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2025-2030)
    Table 70. Hisamitsu Pharmaceutical Corporation Information
    Table 71. Hisamitsu Pharmaceutical Description and Business Overview
    Table 72. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product
    Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
    Table 75. Johnson & Johnson Corporation Information
    Table 76. Johnson & Johnson Description and Business Overview
    Table 77. Johnson & Johnson Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Johnson & Johnson Transdermal Analgesic Patch Product
    Table 79. Johnson & Johnson Recent Developments/Updates
    Table 80. Mylan Corporation Information
    Table 81. Mylan Description and Business Overview
    Table 82. Mylan Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Mylan Transdermal Analgesic Patch Product
    Table 84. Mylan Recent Developments/Updates
    Table 85. UCB Pharma Corporation Information
    Table 86. UCB Pharma Description and Business Overview
    Table 87. UCB Pharma Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. UCB Pharma Transdermal Analgesic Patch Product
    Table 89. UCB Pharma Recent Developments/Updates
    Table 90. Novartis Corporation Information
    Table 91. Novartis Description and Business Overview
    Table 92. Novartis Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Novartis Transdermal Analgesic Patch Product
    Table 94. Novartis Recent Developments/Updates
    Table 95. Teva Pharmaceutical Corporation Information
    Table 96. Teva Pharmaceutical Description and Business Overview
    Table 97. Teva Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Teva Pharmaceutical Transdermal Analgesic Patch Product
    Table 99. Teva Pharmaceutical Recent Developments/Updates
    Table 100. Beijing Tide Pharmaceutical Corporation Information
    Table 101. Beijing Tide Pharmaceutical Description and Business Overview
    Table 102. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product
    Table 104. Beijing Tide Pharmaceutical Recent Developments/Updates
    Table 105. Chattem Corporation Information
    Table 106. Chattem Description and Business Overview
    Table 107. Chattem Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Chattem Transdermal Analgesic Patch Product
    Table 109. Chattem Recent Developments/Updates
    Table 110. Nitto Denko Corporation Information
    Table 111. Nitto Denko Description and Business Overview
    Table 112. Nitto Denko Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Nitto Denko Transdermal Analgesic Patch Product
    Table 114. Nitto Denko Recent Developments/Updates
    Table 115. Grünenthal Corporation Information
    Table 116. Grünenthal Description and Business Overview
    Table 117. Grünenthal Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Grünenthal Transdermal Analgesic Patch Product
    Table 119. Grünenthal Recent Developments/Updates
    Table 120. Mundipharma Corporation Information
    Table 121. Mundipharma Description and Business Overview
    Table 122. Mundipharma Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Mundipharma Transdermal Analgesic Patch Product
    Table 124. Mundipharma Recent Developments/Updates
    Table 125. GSK Corporation Information
    Table 126. GSK Description and Business Overview
    Table 127. GSK Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. GSK Transdermal Analgesic Patch Product
    Table 129. GSK Recent Developments/Updates
    Table 130. Luye Pharma Group Corporation Information
    Table 131. Luye Pharma Group Description and Business Overview
    Table 132. Luye Pharma Group Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Luye Pharma Group Transdermal Analgesic Patch Product
    Table 134. Luye Pharma Group Recent Developments/Updates
    Table 135. Bayer Corporation Information
    Table 136. Bayer Description and Business Overview
    Table 137. Bayer Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Bayer Transdermal Analgesic Patch Product
    Table 139. Bayer Recent Developments/Updates
    Table 140. IBSA Group Corporation Information
    Table 141. IBSA Group Description and Business Overview
    Table 142. IBSA Group Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. IBSA Group Transdermal Analgesic Patch Product
    Table 144. IBSA Group Recent Developments/Updates
    Table 145. Dr Reddy’s Laboratories Corporation Information
    Table 146. Dr Reddy’s Laboratories Description and Business Overview
    Table 147. Dr Reddy’s Laboratories Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Dr Reddy’s Laboratories Transdermal Analgesic Patch Product
    Table 149. Dr Reddy’s Laboratories Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Transdermal Analgesic Patch Distributors List
    Table 153. Transdermal Analgesic Patch Customers List
    Table 154. Transdermal Analgesic Patch Market Trends
    Table 155. Transdermal Analgesic Patch Market Drivers
    Table 156. Transdermal Analgesic Patch Market Challenges
    Table 157. Transdermal Analgesic Patch Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Transdermal Analgesic Patch
    Figure 2. Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Transdermal Analgesic Patch Market Share by Type in 2023 & 2030
    Figure 4. Methyl Salicylate-based Patch Product Picture
    Figure 5. Rivastigmine Transdermal Patch Product Picture
    Figure 6. Fentanyl Transdermal Patch Product Picture
    Figure 7. Lidocaine Patch Product Picture
    Figure 8. Diclofenac Patch Product Picture
    Figure 9. Nicotine Transdermal Patch Product Picture
    Figure 10. Others Product Picture
    Figure 11. Global Transdermal Analgesic Patch Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 12. Global Transdermal Analgesic Patch Market Share by Application in 2023 & 2030
    Figure 13. Rx Channel
    Figure 14. OTC Channel
    Figure 15. Global Transdermal Analgesic Patch Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Transdermal Analgesic Patch Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Transdermal Analgesic Patch Sales (2019-2030) & (K Units)
    Figure 18. Global Transdermal Analgesic Patch Average Price (US$/Unit) & (2019-2030)
    Figure 19. Transdermal Analgesic Patch Report Years Considered
    Figure 20. Transdermal Analgesic Patch Sales Share by Manufacturers in 2023
    Figure 21. Global Transdermal Analgesic Patch Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Transdermal Analgesic Patch Players: Market Share by Revenue in 2023
    Figure 23. Transdermal Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Transdermal Analgesic Patch Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Transdermal Analgesic Patch Sales Market Share by Country (2019-2030)
    Figure 26. North America Transdermal Analgesic Patch Revenue Market Share by Country (2019-2030)
    Figure 27. United States Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Transdermal Analgesic Patch Sales Market Share by Country (2019-2030)
    Figure 30. Europe Transdermal Analgesic Patch Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Transdermal Analgesic Patch Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Transdermal Analgesic Patch Revenue Market Share by Region (2019-2030)
    Figure 38. China Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Transdermal Analgesic Patch Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Transdermal Analgesic Patch Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Transdermal Analgesic Patch Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Transdermal Analgesic Patch Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Transdermal Analgesic Patch by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Transdermal Analgesic Patch by Type (2019-2030)
    Figure 57. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Transdermal Analgesic Patch by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Transdermal Analgesic Patch by Application (2019-2030)
    Figure 60. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2019-2030)
    Figure 61. Transdermal Analgesic Patch Value Chain
    Figure 62. Transdermal Analgesic Patch Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

OTC Transdermal Analgesic Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Analgesics Market Research Report 2024
Global Transdermal Transmission Patches Market Research Report 2024
Global Transdermal Skin Patch Market Research Report 2025
Global Non opioid Analgesic Patch Market Research Report 2024
Global Pain Patches Market Research Report 2024
Global Transdermal Skin Patches Market Research Report 2024
Global Transdermal Absorption Patch Market Research Report 2025
Transdermal Nicotine Patch Market
Global Heat Patches for Pain Relief Market Research Report 2024
Global Pain Relief Heat Patch Market Research Report 2024
Global Contraceptive Transdermal Patche Market Research Report 2024
Global Opioid Pain Patche Market Research Report 2024
Global Transdermal Patch Production Equipment Market Research Report 2024
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Transdermal Patch Market Research Report 2025
Global Absorbable Transdermal Patch Market Research Report 2024
Global Non opioid Pain Patches Market Research Report 2024
Nicotine Transdermal Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ketoprofen Patches Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions